mimAb1

And the Obesity Plot Thickens
Motley Fool
Wed, 01/2/13 - 11:58 am
obesity
Vivus
Arena Pharmaceuticals
Roche
Orexigen
mimAb1
Amgen
Zafgen
Belviq
Qsymia
beloranib
Contrave